Moreau Richard
Inserm, U1149, Centre de Recherche sur l'Inflammation (CRI), Clichy and Paris, France.
UMRS1149, Université Paris Diderot-Paris 7, Paris, France.
Clin Mol Hepatol. 2016 Mar;22(1):1-6. doi: 10.3350/cmh.2016.22.1.1. Epub 2016 Mar 28.
Patients with cirrhosis who are hospitalized for an acute decompensation (AD) and also have organ failure(s) are at high risk of short-term death. These patients have a syndrome called Acute-on-Chronic Liver Failure (ACLF). ACLF is now considered as a new syndrome that it is distinct from "mere" AD not only because of the presence of organ failure(s) and high short-term mortality but also because of younger age, higher prevalence of alcoholic etiology of cirrhosis, higher prevalence of some precipitants (such as bacterial infections, active alcoholism), and more intense systemic inflammatory response. ACLF is a new syndrome also because severe sepsis or severe alcoholic hepatitis do not account for 100% of the observed cases; in fact, almost 50% of the cases are of "unknown" origin. In other words, severe sepsis, severe alcoholic hepatitis and ACLF of "unknown origin" are subcategories of the syndrome.
因急性失代偿(AD)住院且伴有器官衰竭的肝硬化患者短期死亡风险很高。这些患者患有一种名为慢加急性肝衰竭(ACLF)的综合征。ACLF现在被认为是一种新的综合征,它与“单纯的”AD不同,不仅因为存在器官衰竭和高短期死亡率,还因为患者年龄较轻、酒精性肝硬化病因的患病率较高、某些诱因(如细菌感染、酒精滥用)的患病率较高以及全身炎症反应更强烈。ACLF也是一种新综合征,因为严重脓毒症或严重酒精性肝炎并不能解释所有观察到的病例;事实上,几乎50%的病例病因“不明”。换句话说,严重脓毒症、严重酒精性肝炎和病因“不明”的ACLF是该综合征的子类别。